Form 4: Fate Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Cindy Tahl, See Remarks of Fate Therapeutics Inc, sold 38,800 shares of common stock on August 4, 2026 for $2.46 per share.
Summary
- Open-market sale: disposed of 38,800 Common Stock at $2.46 ($95,405) on August 4, 2026; holds 589,355 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $95,405 of stock on the open market.
Insider Transactions
Cindy Tahl — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Open-market sale | Common Stock | 38,800 | $2 | $95.4K | 589,355 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Open-market sale (38,800 shares) |
Keywords
insider transaction, Form 4, FATE, FATE THERAPEUTICS INC, bearish, Cindy Tahl
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.